Compared with the control group, antibody against C/EBP-β significantly increased the interaction with SOD2 intronic enhancer following PTE treatment during the reactivation of quiescent PCa cells (Fig. 5E). The gene discussed is CEBPB; the disease is posterior cortical atrophy.